Pharmaceutical Intermediate API 99% Tadalafil 171596-29-5 pẹlu idiyele to dara ati ifijiṣẹ yarayara
ọja alaye
Orukọ ọja | Tadalafil |
Awọn itumọ ọrọ sisọ | TADALAFIL; CIALIS; IC 351; (6R,12AR) -6- (benzo [d][1,3] dioxol-5-yl) -2-methyl-2,3,12,12a-tetrahydropyrazino [1',2] '1,6]pyrido; GF 196960; ICOS 351; Tildenafil; UK 336017 |
CAS | 171596-29-5 |
MF | C22H19N3O4 |
MW | 389.4 |
EINECS | 687-782-2 |
Ojuami yo | 298-300°C |
alfa | D20 +71,0 ° |
Oju omi farabale | 679.1± 55.0 °C(Asọtẹlẹ) |
iwuwo | 1.51± 0.1 g/cm3(Asọtẹlẹ) |
Fp | 2℃ |
Iwọn otutu ipamọ. | Ti di ni gbẹ, 2-8 ° C |
Solubility | DMSO tiotuka20mg/ml, ko o |
Fọọmu | lulú |
pka | 16.68± 0.40 (Asọtẹlẹ) |
Àwọ̀ | funfun si alagara |
Iduroṣinṣin | Riru ni kẹmika |
Lilo | Ma ṣe ta si ti ara ẹni, fun iwadii nikan |
Ibi ipamọ | Jeki ni itura, ibi gbigbẹ, apoti ti a fi idi mu ni wiwọ |
Gbigbe | Iwọn otutu yara |
Igbesi aye selifu | ≥ 2 ọdun |
Ipo | O wa |
ọja Awọn aworan
Ọrọ Iṣaaju kukuru
Kini Tadalafil | Tadalafil (orukọ ọja "Cialis" tabi "Adcirca") jẹ idagbasoke nipasẹ ile-iṣẹ oogun Amẹrika Lilly.O jẹ iru ti PDE5 inhibitor ti a lo fun itọju aiṣedede erectile, hypertrophy prostatic benign and pulmonary arterial haipatensonu.Ipa ti Tadalafil ti wa ni isinmi awọn iṣan ẹjẹ ati jijẹ sisan ẹjẹ sinu cavernosum corpus. |
Iṣakojọpọ ọja
Iwọn iṣakojọpọ: 1g; 5g; 10g; 50g; 100g; 1kg Awọn apo apamọwọ;25kg ilu
Iṣakojọpọ adani wa
Gbigbe
KIAKIA (ọjọ 3-8) | DHL/TNT/Fedex |
Nipasẹ afẹfẹ (ọjọ 8-15) | Si papa ọkọ ofurufu nikan, alabara pẹlu ifasilẹ kọsitọmu ni papa ọkọ ofurufu ti nlo; Dara fun opoiye nla bi 50kg si awọn ọgọọgọrun kgs |
Ilekun si ẹnu-ọna (ọjọ 8-15) | Most daradara ọna labẹ 100kg Special ila iṣẹ |
Nipa Okun (ọjọ 20-40) | Si ibudokọ oju omi nikan, alabara ṣe adehun pẹlu idasilẹ kọsitọmu ni ibudo oju omi irin ajo;Dara fun awọn ẹru nla, awọn ọgọọgọrun ti kgs si eiyan; din owo ṣugbọn akoko to gun. |
Awọn anfani wa
Kọ ifiranṣẹ rẹ nibi ki o si fi si wa